In a challenging environment, RPG Life Sciences has had discussions with 13 of its international customers to help absorb escalating input costs, and that has reflected in its financial performance in the first three months of the quarter (Q1 FY27), said Ashok Nair, RPGLS Managing Director, even as he outlined plans to acquire a manufacturing facility, besides launching weight loss and diabetes drug semaglutide.
No articles in the last 24 hours. Expand to 1 week
